Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Surgical Oncology
What is the evidence supporting and role of LYMPHA for breast cancer?
How do you counsel patients for whom it is not covered by insurance?
Related Questions
Is a skin sparing mastectomy appropriate in a patient with cT4b, ypT3 breast cancer with skin ulceration who receives neoadjuvant chemotherapy with a partial response?
What is the accuracy of SNB in the setting of bilateral axillary hidradenitis?
For a pedunculated rectal polyp found to be adenocarcinoma after endoscopic removal, with PNI as the only adverse feature, would you recommend additional treatment such as surgery or chemoradiation?
In a patient with stage III pure seminoma testicular cancer with positive margins following surgery, is there any role for targeted radiation or additional surgery for the positive margin?
Would you give adjuvant TDM-1 to a patient with HER2-positive breast cancer s/p NAC with TCHP found to have no residual disease in the breast, but presence of residual disease in one axillary lymph node?